Buyco, Avelino Iii C.

HRN: 26-87-60  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2025
CEFTRIAXONE 1G (VIAL)
03/28/2025
04/04/2025
IV
2g
OD
CAP MR
Waiting Final Action 
03/28/2025
AZITHROMYCIN 500MG TABLET (TAB)
03/28/2025
04/02/2025
PO
500mg
OD
CAP MR
Waiting Final Action 
03/28/2025
COTRIMOXAZOLE 960MG (TAB)
03/28/2025
04/17/2025
PO
960 Tab
TID
Immunocompromised
Waiting Final Action 
03/28/2025
FLUCONAZOLE 150MG (CAP)
03/28/2025
04/11/2025
PO
150mg
OD
Immunocompromised
Waiting Final Action 
03/29/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/29/2025
04/04/2025
PO
5cc
TID
Oral Candidiasis
Waiting Final Action 
03/29/2025
BENZYL PENICILLIN 1MU (VIAL)
03/29/2025
03/29/2025
IM
2.4 MU
1 Dose
Syphilis Infection
Waiting Final Action 
04/05/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/05/2025
04/12/2025
PO
5cc
TID
Oral Candidiasis
Waiting Final Action 
04/05/2025
FLUCONAZOLE 150MG (CAP)
04/05/2025
04/12/2025
PO
1 Cap
OD
Immunocompromised
Waiting Final Action 
04/05/2025
COTRIMOXAZOLE 960MG (TAB)
04/05/2025
04/12/2025
PO
960mg
TID
Immunocompromised
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: